[Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
Dalaker
Morten
M
Hudavdelingen St. Olavs Hospital 7006 Trondheim. morten.dalaker@stolav.no
Bonesrønning
Jon Helge
JH
D000169:Acrodermatitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008727:Methotrexate